Article

Multiple Myeloma DREAM Challenge Reveals Epigenetic Regulator <i>PHF19</i> As Marker of Aggressive Disease

2019-08-22

Abstract excerpt

While the past decade has seen meaningful improvements in clinical outcomes for multiple myeloma patients, a subset of patients do not benefit from current therapeutics for unclear reasons. Many gene expression-based models of risk have been developed, but each model uses a different combination of genes and often involve assaying many genes making them difficult to implement. We organized the Multiple Myeloma DRE...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 156bfd2d-6889-5c76-acec-7698c5176ed4
DOI: 10.1101/737122

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multiple Myeloma DREAM Challenge Reveals Epigenetic Regulator <i>PHF19</i> As Marker of Aggressive DiseaseDOI 10.1101/737122Read

Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive diseaseSemantic proximity Read

High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitionsSemantic proximity Read

Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profilingSemantic proximity Read

Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes.Semantic proximity Read

Genetic Subtypes of Smoldering Multiple Myeloma are associated with Distinct Pathogenic Phenotypes and Clinical OutcomesSemantic proximity Read

1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma.Semantic proximity Read

Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myelomaSemantic proximity Read

Identification of clinical implications and potential prognostic models of chromatin regulator mutations in multiple myeloma.Semantic proximity Read

Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancerSemantic proximity Read

Mapping Disease Transitions from Premalignant, Asymptomatic to Advanced Myeloma through Integrative Epigenomic and Transcriptional AnalysesSemantic proximity Read

Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging SystemSemantic proximity Read

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysisSemantic proximity Read